论文部分内容阅读
背景:FRISC-II有创性试验将非ST段抬高型急性冠状动脉综合征患者经早期有创和无创策略治疗后的死亡率和心肌梗死发生率进行了比较。本文基于推荐的风险分层标准展示了整体及亚组患者的5年随访结果。
Background: The FRISC-II invasive trial compared mortality and myocardial infarction rates in patients with non-ST-segment elevation acute coronary syndrome treated with early invasive and noninvasive strategies. This article presents a 5-year follow-up of patients in both groups as a whole and in subgroups based on the recommended risk stratification criteria.